AcquisitionOther

Ambrx Biopharma Inc. acquired Ambrx surviving the Merger as a direct wholly owned subsidiary of NewCo. Upon completion of the Merger, NewCo would,

Name: Ambrx Biopharma Inc. acquired Ambrx surviving the Merger as a direct wholly owned subsidiary of NewCo. Upon completion of the Merger, NewCo would,
Start: 2023-09-15

Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.

Deal tape row

Ambrx Biopharma Inc. -> Ambrx surviving the Merger as a direct wholly owned subsidiary of NewCo. Upon completion of the Merger, NewCo would, · $15,000

Open source record (SEC) ↗